Search research articles
Contact Us
Filters
Showing results (231-240 of 270) with videos related to
Page
of 27
Sort By:
Frontiers in Molecular Biosciences
|
December 25, 2025
Sex-dependent alterations of salivary microbiome in Parkinson's disease: associations with motor and non-motor clinical phenotypes
Jie Zu, Wei Zhang, Li Du, et al.
Parkinsonism & Related Disorders
|
August 13, 2013
The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: a multicenter, double-blind, randomized, placebo-controlled study
Zhenxin Zhang, Jian Wang, Xiaoying Zhang, et al.
Current Medical Research and Opinion
|
January 15, 2015
An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson's disease
Zhenxin Zhang, Jian Wang, Xiaoying Zhang, et al.
Frontiers in Neurology
|
December 5, 2025
Levodopa/carbidopa/entacapone versus levodopa/benserazide plus pramipexole in Chinese patients with Parkinson's disease experiencing wearing off
Cuiyu Yu, Weiguo Liu, Aiping Gong, et al.
Frontiers in Immunology
|
January 23, 2023
Phenotypic and functional alteration of CD45+ immune cells in the decidua of preeclampsia patients analyzed by mass cytometry (CyTOF)
Min Fu, Xiaowei Zhang, Chunfeng Liu, et al.
Frontiers in Psychiatry
|
April 29, 2025
Reducing the risk of perinatal depression using an app-based cognitive behavioral therapy program: protocol of a randomized controlled trial
Li Tang, Hua Qing, Hong Li, et al.
Cerebellum (London, England)
|
November 26, 2022
Immunotherapies for the Effective Treatment of Primary Autoimmune Cerebellar Ataxia: a Case Series
Jiao Li, Bo Deng, Wenli Song, et al.
CNS Drugs
|
November 8, 2022
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor Fluctuations
Qianqian Wei, Yuyan Tan, Pingyi Xu, et al.
Sleep Medicine
|
July 14, 2024
Changes in slow-wave sleep characteristics in Parkinson's disease patients with mild-moderate depression
Jingzhe Hu, Jiayu Wu, Qiming Jiang, et al.
Communications Biology
|
September 17, 2021
Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment
Ravi Chakra Turaga, Ganesh Satyanarayana, Malvika Sharma, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 270) with videos related to
Sort By:
Page
of 27
Frontiers in Molecular Biosciences
|
December 25, 2025
Sex-dependent alterations of salivary microbiome in Parkinson's disease: associations with motor and non-motor clinical phenotypes
Jie Zu, Wei Zhang, Li Du, et al.
Parkinsonism & Related Disorders
|
August 13, 2013
The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: a multicenter, double-blind, randomized, placebo-controlled study
Zhenxin Zhang, Jian Wang, Xiaoying Zhang, et al.
Current Medical Research and Opinion
|
January 15, 2015
An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson's disease
Zhenxin Zhang, Jian Wang, Xiaoying Zhang, et al.
Frontiers in Neurology
|
December 5, 2025
Levodopa/carbidopa/entacapone versus levodopa/benserazide plus pramipexole in Chinese patients with Parkinson's disease experiencing wearing off
Cuiyu Yu, Weiguo Liu, Aiping Gong, et al.
Frontiers in Immunology
|
January 23, 2023
Phenotypic and functional alteration of CD45+ immune cells in the decidua of preeclampsia patients analyzed by mass cytometry (CyTOF)
Min Fu, Xiaowei Zhang, Chunfeng Liu, et al.
Frontiers in Psychiatry
|
April 29, 2025
Reducing the risk of perinatal depression using an app-based cognitive behavioral therapy program: protocol of a randomized controlled trial
Li Tang, Hua Qing, Hong Li, et al.
Cerebellum (London, England)
|
November 26, 2022
Immunotherapies for the Effective Treatment of Primary Autoimmune Cerebellar Ataxia: a Case Series
Jiao Li, Bo Deng, Wenli Song, et al.
CNS Drugs
|
November 8, 2022
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor Fluctuations
Qianqian Wei, Yuyan Tan, Pingyi Xu, et al.
Sleep Medicine
|
July 14, 2024
Changes in slow-wave sleep characteristics in Parkinson's disease patients with mild-moderate depression
Jingzhe Hu, Jiayu Wu, Qiming Jiang, et al.
Communications Biology
|
September 17, 2021
Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment
Ravi Chakra Turaga, Ganesh Satyanarayana, Malvika Sharma, et al.
Page
of 27